PRKN and Parkinson disease: In addition, in DA neurons differentiated from iPSCs derived from PD patients with PARK2 mutations, the expression of TMEM175 was significantly downregulated (p = 4.60E‐02) (Figure 3D), whereas no significant difference was detected in neural progenitor cells.